Latest Insider Transactions at Clearside Biomedical, Inc. (CLSD)
This section provides a real-time view of insider transactions for Clearside Biomedical, Inc. (CLSD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Clearside Biomedical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Clearside Biomedical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 18
2021
|
Charles A. Deignan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
96,360
+23.02%
|
-
|
|
Jan 18
2021
|
George M Lasezkay CEO |
BUY
Grant, award, or other acquisition
|
Direct |
140,250
+24.19%
|
-
|
|
Jan 06
2021
|
Bradford T Whitmore > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
350,750
+9.04%
|
$701,500
$2.85 P/Share
|
|
Dec 24
2020
|
Bradford T Whitmore > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
51,195
+1.58%
|
$51,195
$1.95 P/Share
|
|
Dec 21
2020
|
George M Lasezkay CEO |
SELL
Open market or private sale
|
Direct |
3,330
-1.1%
|
$6,660
$2.07 P/Share
|
|
Dec 02
2020
|
Bradford T Whitmore > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
53,900
+1.69%
|
$53,900
$1.95 P/Share
|
|
Nov 24
2020
|
Bradford T Whitmore > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,000
+1.98%
|
$62,000
$1.65 P/Share
|
|
Nov 16
2020
|
Bradford T Whitmore > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,000
+2.02%
|
$62,000
$1.69 P/Share
|